Therapie des akuten Lungenversagens in einem Behandlungszentrum

Abstract

Advanced treatment of ARDS including ECMO represents a therapeutic option if none of the currently considered contraindications are present. An improvement in gas exchange parameters, but not a defined value per se may be useful as a prognostic factor for favourable outcome.

Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure

“…When combining the mortality and the 6‐month disability end points, the difference became significant in favour of the ECMO group . However, the study has attracted some criticism why the ‘evidence’ adult ECMO in the treatment of severe ARDS is still largely based on non‐randomised studies published by a number of ECMO centres . Nevertheless, ECMO treatment has a place in clinical practice, as indicated by the Extracorporeal Life Support Organisation (ELSO) International Registry Report from January 2011, in which the number of adult ECMO treatments more than doubled during the H1N1 pandemic.…”